{"id":"W2106545303","doi":"10.1016/j.cell.2010.07.044","title":"Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma","year":2010,"lang":"en","type":"article","venue":"Cell","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1080,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; Wellcome Trust; Howard Hughes Medical Institute","keywords":"Rituximab; CD47; Lymphoma; Monoclonal antibody; Antibody; Immunology; CD20; Cancer research; Biology; Monoclonal antibody therapy; Blocking antibody; Medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008555843,0.0006355013,0.001148203,0.0006612243,0.0003519657,0.0007325201,0.0004958473,0.0006931928,0.0022597],"category_scores_gemma":[0.0005336519,0.0003579584,0.0006085125,0.0002784905,0.0003853214,0.0005192118,0.0004749111,0.001126879,0.0009475026],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004691867,"about_ca_system_score_gemma":0.0004554999,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002980852,"about_ca_topic_score_gemma":0.0009024282,"domain_scores_codex":[0.9993427,0.0002339769,0.0000459621,0.00004227481,0.000111594,0.0002233364],"domain_scores_gemma":[0.9997039,0.00009982575,0.00004356716,0.000045255,0.00002226696,0.00008510274],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01898584,0.005563254,0.003471274,0.0006251069,0.0004647079,0.001064635,0.00009787374,0.001261432,0.8567662,0.001361747,0.007030266,0.1033076],"study_design_scores_gemma":[0.01042269,0.0368882,0.03503209,0.00009793765,0.0008723038,0.00674893,0.0001810318,0.006538044,0.8741581,0.000763515,0.02824573,0.00005136088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9819396,0.008605991,0.001149383,0.0005305887,0.0003024053,0.0001545463,0.0001276973,0.0002703502,0.006919397],"genre_scores_gemma":[0.9952759,0.001605436,0.0008336353,0.0002249982,0.0002192847,0.00007884805,0.0002273932,0.0000242806,0.0015103],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0022597,"threshold_uncertainty_score":0.007559478,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009338248667400371,"score_gpt":0.2858738822716768,"score_spread":0.2765356336042765,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}